nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—ABCA3—medulla oblongata—meningioma	0.0103	0.0395	CbGeAlD
Imatinib—DDR1—medulla oblongata—meningioma	0.00947	0.0364	CbGeAlD
Imatinib—ABCA3—spinal cord—meningioma	0.00915	0.0352	CbGeAlD
Imatinib—DDR1—spinal cord—meningioma	0.00845	0.0325	CbGeAlD
Imatinib—ABCA3—cerebellum—meningioma	0.00726	0.0279	CbGeAlD
Imatinib—DDR1—cerebellum—meningioma	0.0067	0.0258	CbGeAlD
Imatinib—NQO2—brainstem—meningioma	0.00616	0.0237	CbGeAlD
Imatinib—HIPK4—brain—meningioma	0.00596	0.0229	CbGeAlD
Imatinib—ABCA3—brain—meningioma	0.0059	0.0227	CbGeAlD
Imatinib—PIP4K2C—medulla oblongata—meningioma	0.00585	0.0225	CbGeAlD
Imatinib—DDR1—brain—meningioma	0.00544	0.0209	CbGeAlD
Imatinib—PIP4K2C—spinal cord—meningioma	0.00521	0.0201	CbGeAlD
Imatinib—CA14—medulla oblongata—meningioma	0.00507	0.0195	CbGeAlD
Imatinib—SLC47A1—brainstem—meningioma	0.00494	0.019	CbGeAlD
Imatinib—KIT—brainstem—meningioma	0.00491	0.0189	CbGeAlD
Imatinib—CA14—spinal cord—meningioma	0.00452	0.0174	CbGeAlD
Imatinib—ABL2—cerebellum—meningioma	0.00437	0.0168	CbGeAlD
Imatinib—CA7—cerebellum—meningioma	0.0043	0.0166	CbGeAlD
Imatinib—NQO2—medulla oblongata—meningioma	0.00429	0.0165	CbGeAlD
Imatinib—ABL1—brainstem—meningioma	0.00428	0.0164	CbGeAlD
Imatinib—PIP4K2C—cerebellum—meningioma	0.00413	0.0159	CbGeAlD
Imatinib—NQO2—spinal cord—meningioma	0.00383	0.0147	CbGeAlD
Imatinib—PDGFRA—spinal cord—meningioma	0.00382	0.0147	CbGeAlD
Imatinib—CA9—cerebellum—meningioma	0.00378	0.0145	CbGeAlD
Imatinib—CSF1R—medulla oblongata—meningioma	0.00377	0.0145	CbGeAlD
Imatinib—CA14—cerebellum—meningioma	0.00358	0.0138	CbGeAlD
Imatinib—ABL2—brain—meningioma	0.00355	0.0137	CbGeAlD
Imatinib—CA7—brain—meningioma	0.0035	0.0134	CbGeAlD
Imatinib—SLC47A1—medulla oblongata—meningioma	0.00344	0.0132	CbGeAlD
Imatinib—KIT—medulla oblongata—meningioma	0.00342	0.0132	CbGeAlD
Imatinib—CSF1R—spinal cord—meningioma	0.00336	0.0129	CbGeAlD
Imatinib—PIP4K2C—brain—meningioma	0.00336	0.0129	CbGeAlD
Imatinib—PDGFRB—medulla oblongata—meningioma	0.00334	0.0129	CbGeAlD
Imatinib—CA3—brain—meningioma	0.00321	0.0123	CbGeAlD
Imatinib—SLC47A1—spinal cord—meningioma	0.00307	0.0118	CbGeAlD
Imatinib—KIT—spinal cord—meningioma	0.00305	0.0117	CbGeAlD
Imatinib—NQO2—cerebellum—meningioma	0.00304	0.0117	CbGeAlD
Imatinib—PDGFRA—cerebellum—meningioma	0.00303	0.0116	CbGeAlD
Imatinib—PDGFRB—spinal cord—meningioma	0.00298	0.0115	CbGeAlD
Imatinib—ABL1—medulla oblongata—meningioma	0.00298	0.0115	CbGeAlD
Imatinib—CA14—brain—meningioma	0.00291	0.0112	CbGeAlD
Imatinib—CA2—brainstem—meningioma	0.00291	0.0112	CbGeAlD
Imatinib—ORM1—spinal cord—meningioma	0.0028	0.0108	CbGeAlD
Imatinib—CA1—spinal cord—meningioma	0.00279	0.0107	CbGeAlD
Imatinib—CSF1R—cerebellum—meningioma	0.00267	0.0103	CbGeAlD
Imatinib—ABL1—spinal cord—meningioma	0.00266	0.0102	CbGeAlD
Imatinib—NQO2—brain—meningioma	0.00247	0.00949	CbGeAlD
Imatinib—PDGFRA—brain—meningioma	0.00246	0.00946	CbGeAlD
Imatinib—SLC47A1—cerebellum—meningioma	0.00244	0.00937	CbGeAlD
Imatinib—KIT—cerebellum—meningioma	0.00242	0.00931	CbGeAlD
Imatinib—PDGFRB—cerebellum—meningioma	0.00237	0.0091	CbGeAlD
Imatinib—CA12—brain—meningioma	0.00227	0.00873	CbGeAlD
Imatinib—CSF1R—brain—meningioma	0.00217	0.00833	CbGeAlD
Imatinib—ABL1—cerebellum—meningioma	0.00211	0.00811	CbGeAlD
Imatinib—CA2—medulla oblongata—meningioma	0.00203	0.00781	CbGeAlD
Imatinib—SLC47A1—brain—meningioma	0.00198	0.00761	CbGeAlD
Imatinib—KIT—brain—meningioma	0.00197	0.00756	CbGeAlD
Imatinib—PDGFRB—brain—meningioma	0.00192	0.00739	CbGeAlD
Imatinib—ABCG2—medulla oblongata—meningioma	0.00188	0.00723	CbGeAlD
Imatinib—CYP2D6—brainstem—meningioma	0.00185	0.00711	CbGeAlD
Imatinib—CA2—spinal cord—meningioma	0.00181	0.00696	CbGeAlD
Imatinib—CA1—brain—meningioma	0.0018	0.00692	CbGeAlD
Imatinib—ABL1—brain—meningioma	0.00171	0.00659	CbGeAlD
Imatinib—ABCG2—spinal cord—meningioma	0.00168	0.00645	CbGeAlD
Imatinib—SLC22A1—brain—meningioma	0.00165	0.00635	CbGeAlD
Imatinib—ALB—brain—meningioma	0.00158	0.00608	CbGeAlD
Imatinib—CA2—cerebellum—meningioma	0.00144	0.00552	CbGeAlD
Imatinib—PTGS1—spinal cord—meningioma	0.0014	0.00538	CbGeAlD
Imatinib—ABCG2—cerebellum—meningioma	0.00133	0.00511	CbGeAlD
Imatinib—CA2—brain—meningioma	0.00117	0.00448	CbGeAlD
Imatinib—ABCG2—brain—meningioma	0.00108	0.00415	CbGeAlD
Imatinib—ABCB1—medulla oblongata—meningioma	0.000927	0.00357	CbGeAlD
Imatinib—CYP2D6—cerebellum—meningioma	0.000911	0.0035	CbGeAlD
Imatinib—PTGS1—brain—meningioma	0.000901	0.00346	CbGeAlD
Imatinib—ABCB1—spinal cord—meningioma	0.000827	0.00318	CbGeAlD
Imatinib—CYP2D6—brain—meningioma	0.00074	0.00285	CbGeAlD
Imatinib—ABCB1—cerebellum—meningioma	0.000656	0.00252	CbGeAlD
Imatinib—ABCB1—brain—meningioma	0.000532	0.00205	CbGeAlD
Imatinib—PDGFRA—DAP12 interactions—AKT1—meningioma	0.000324	0.000438	CbGpPWpGaD
Imatinib—ABL1—Integrated Breast Cancer Pathway—AKT1—meningioma	0.000323	0.000436	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by EGFR—AKT1—meningioma	0.000321	0.000434	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TSHB—meningioma	0.000319	0.000431	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by EGFR in Cancer—AKT1—meningioma	0.000318	0.00043	CbGpPWpGaD
Imatinib—NTRK1—Signaling by NGF—AKT1—meningioma	0.000318	0.00043	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.000317	0.000428	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by PDGF—AKT1—meningioma	0.000317	0.000428	CbGpPWpGaD
Imatinib—KIT—B Cell Activation—AKT1—meningioma	0.000317	0.000428	CbGpPWpGaD
Imatinib—PDGFRB—Downstream signal transduction—AKT1—meningioma	0.000315	0.000425	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by FGFR—AKT1—meningioma	0.000313	0.000423	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by ERBB2—AKT1—meningioma	0.000312	0.000421	CbGpPWpGaD
Imatinib—PDGFRB—DAP12 signaling—AKT1—meningioma	0.00031	0.000419	CbGpPWpGaD
Imatinib—LCK—Hemostasis—PDGFB—meningioma	0.000307	0.000415	CbGpPWpGaD
Imatinib—PDGFRA—Focal Adhesion—AKT1—meningioma	0.000306	0.000414	CbGpPWpGaD
Imatinib—PDGFRB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.000306	0.000413	CbGpPWpGaD
Imatinib—ABL1—EGF/EGFR Signaling Pathway—AKT1—meningioma	0.000305	0.000413	CbGpPWpGaD
Imatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000305	0.000412	CbGpPWpGaD
Imatinib—PDGFRB—MAPK Signaling Pathway—AKT1—meningioma	0.000304	0.000411	CbGpPWpGaD
Imatinib—KIT—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000303	0.00041	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TSHB—meningioma	0.000302	0.000408	CbGpPWpGaD
Imatinib—PDGFRA—B Cell Activation—AKT1—meningioma	0.0003	0.000405	CbGpPWpGaD
Imatinib—LCK—Hemostasis—PLAU—meningioma	0.000298	0.000402	CbGpPWpGaD
Imatinib—LCK—Disease—CST3—meningioma	0.000295	0.000399	CbGpPWpGaD
Imatinib—PDGFRB—DAP12 interactions—AKT1—meningioma	0.000292	0.000394	CbGpPWpGaD
Imatinib—PDGFRB—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.000292	0.000394	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by FGFR in disease—AKT1—meningioma	0.000292	0.000394	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by EGFR—AKT1—meningioma	0.000289	0.000391	CbGpPWpGaD
Imatinib—PDGFRA—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000287	0.000388	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by EGFR in Cancer—AKT1—meningioma	0.000287	0.000387	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by PDGF—AKT1—meningioma	0.000285	0.000386	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ALAD—meningioma	0.000281	0.00038	CbGpPWpGaD
Imatinib—LCK—Signaling by SCF-KIT—AKT1—meningioma	0.000281	0.00038	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—PTEN—meningioma	0.000277	0.000374	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—PDGFB—meningioma	0.000276	0.000373	CbGpPWpGaD
Imatinib—PDGFRB—Focal Adhesion—AKT1—meningioma	0.000276	0.000373	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TSHB—meningioma	0.000272	0.000368	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—SMO—meningioma	0.000271	0.000366	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—ERBB2—meningioma	0.000271	0.000366	CbGpPWpGaD
Imatinib—PDGFRB—B Cell Activation—AKT1—meningioma	0.00027	0.000365	CbGpPWpGaD
Imatinib—ABCB1—HIF-1-alpha transcription factor network—AKT1—meningioma	0.00027	0.000365	CbGpPWpGaD
Imatinib—LCK—Downstream signaling of activated FGFR—AKT1—meningioma	0.000269	0.000363	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000268	0.000362	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—PDGFB—meningioma	0.000265	0.000359	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB4—AKT1—meningioma	0.000265	0.000358	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—PGR—meningioma	0.00026	0.000351	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—ERBB2—meningioma	0.00026	0.000351	CbGpPWpGaD
Imatinib—PDGFRB—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000259	0.000349	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—SMO—meningioma	0.000257	0.000347	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—ERBB2—meningioma	0.000256	0.000346	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—ERBB2—meningioma	0.000255	0.000344	CbGpPWpGaD
Imatinib—KIT—Disease—HES1—meningioma	0.000254	0.000343	CbGpPWpGaD
Imatinib—ALB—Hemostasis—PLAUR—meningioma	0.000254	0.000343	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—TSHB—meningioma	0.000253	0.000342	CbGpPWpGaD
Imatinib—LCK—Downstream signal transduction—AKT1—meningioma	0.000253	0.000341	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR—AKT1—meningioma	0.000251	0.00034	CbGpPWpGaD
Imatinib—CA14—Metabolism—PTEN—meningioma	0.000251	0.000339	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—TSHB—meningioma	0.000251	0.000339	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—TSHB—meningioma	0.00025	0.000338	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB2—AKT1—meningioma	0.00025	0.000338	CbGpPWpGaD
Imatinib—LCK—DAP12 signaling—AKT1—meningioma	0.000249	0.000336	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—PGR—meningioma	0.000246	0.000333	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—ERBB2—meningioma	0.000246	0.000332	CbGpPWpGaD
Imatinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.000245	0.000332	CbGpPWpGaD
Imatinib—CA6—Metabolism—PTEN—meningioma	0.000245	0.000331	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—TSHB—meningioma	0.000243	0.000328	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—HES1—meningioma	0.000243	0.000328	CbGpPWpGaD
Imatinib—ALB—Metabolism—ALAD—meningioma	0.000242	0.000327	CbGpPWpGaD
Imatinib—PDGFRA—Disease—HES1—meningioma	0.00024	0.000325	CbGpPWpGaD
Imatinib—KIT—Immune System—PDGFB—meningioma	0.000235	0.000318	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.000235	0.000317	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR in disease—AKT1—meningioma	0.000234	0.000317	CbGpPWpGaD
Imatinib—LCK—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.000234	0.000317	CbGpPWpGaD
Imatinib—LCK—DAP12 interactions—AKT1—meningioma	0.000234	0.000317	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—TSHB—meningioma	0.000233	0.000315	CbGpPWpGaD
Imatinib—KIT—Signaling by NGF—AKT1—meningioma	0.000233	0.000315	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR—AKT1—meningioma	0.000232	0.000314	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—SMO—meningioma	0.000231	0.000313	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—ERBB2—meningioma	0.000231	0.000312	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—PTEN—meningioma	0.000231	0.000312	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR in Cancer—AKT1—meningioma	0.00023	0.000311	CbGpPWpGaD
Imatinib—LCK—Signaling by PDGF—AKT1—meningioma	0.000229	0.00031	CbGpPWpGaD
Imatinib—CA7—Metabolism—PTEN—meningioma	0.000228	0.000309	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—ERBB2—meningioma	0.000225	0.000304	CbGpPWpGaD
Imatinib—CA3—Metabolism—AKT1—meningioma	0.000224	0.000303	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—PDGFB—meningioma	0.000223	0.000301	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—PGR—meningioma	0.000222	0.0003	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—ERBB2—meningioma	0.000222	0.000299	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—PTEN—meningioma	0.000222	0.000299	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by NGF—AKT1—meningioma	0.000221	0.000298	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—PTEN—meningioma	0.000218	0.000295	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TSHB—meningioma	0.000218	0.000295	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ALAD—meningioma	0.000217	0.000294	CbGpPWpGaD
Imatinib—KIT—Disease—PDGFB—meningioma	0.000217	0.000293	CbGpPWpGaD
Imatinib—LCK—B Cell Activation—AKT1—meningioma	0.000217	0.000293	CbGpPWpGaD
Imatinib—PDGFRB—Disease—HES1—meningioma	0.000216	0.000293	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ALAD—meningioma	0.000212	0.000287	CbGpPWpGaD
Imatinib—CA12—Metabolism—PTEN—meningioma	0.000212	0.000286	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—PTEN—meningioma	0.00021	0.000283	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—PDGFB—meningioma	0.000207	0.00028	CbGpPWpGaD
Imatinib—LCK—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000207	0.00028	CbGpPWpGaD
Imatinib—PDGFRA—Disease—PDGFB—meningioma	0.000206	0.000278	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—PDGFB—meningioma	0.000201	0.000271	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.0002	0.000271	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ALAD—meningioma	0.0002	0.00027	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by NGF—AKT1—meningioma	0.000199	0.000269	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ALAD—meningioma	0.000198	0.000268	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—PTEN—meningioma	0.000197	0.000266	CbGpPWpGaD
Imatinib—LCK—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000196	0.000265	CbGpPWpGaD
Imatinib—ABL1—Immune System—PDGFB—meningioma	0.000195	0.000264	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—PTEN—meningioma	0.000192	0.000259	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—PTEN—meningioma	0.000189	0.000255	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—SMO—meningioma	0.000186	0.000251	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—ERBB2—meningioma	0.000185	0.00025	CbGpPWpGaD
Imatinib—PDGFRB—Disease—PDGFB—meningioma	0.000185	0.00025	CbGpPWpGaD
Imatinib—ALB—Hemostasis—PDGFB—meningioma	0.000183	0.000248	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—TSHB—meningioma	0.000181	0.000245	CbGpPWpGaD
Imatinib—ALB—Hemostasis—PLAU—meningioma	0.000178	0.000241	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—PGR—meningioma	0.000178	0.00024	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—ERBB2—meningioma	0.000178	0.00024	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—HES1—meningioma	0.000178	0.00024	CbGpPWpGaD
Imatinib—LCK—Disease—HES1—meningioma	0.000174	0.000235	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ALAD—meningioma	0.000169	0.000229	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—HES1—meningioma	0.000168	0.000227	CbGpPWpGaD
Imatinib—CA2—Metabolism—PTEN—meningioma	0.000162	0.000219	CbGpPWpGaD
Imatinib—LCK—Immune System—PDGFB—meningioma	0.000161	0.000217	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—AKT1—meningioma	0.00016	0.000216	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—PTEN—meningioma	0.000158	0.000213	CbGpPWpGaD
Imatinib—KIT—Immune System—ERBB2—meningioma	0.000158	0.000213	CbGpPWpGaD
Imatinib—ALB—Metabolism—TSHB—meningioma	0.000156	0.000211	CbGpPWpGaD
Imatinib—CA1—Metabolism—PTEN—meningioma	0.000155	0.00021	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—PDGFB—meningioma	0.000152	0.000205	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—PTEN—meningioma	0.000152	0.000205	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HES1—meningioma	0.000152	0.000205	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—ERBB2—meningioma	0.000149	0.000202	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000149	0.000201	CbGpPWpGaD
Imatinib—LCK—Disease—PDGFB—meningioma	0.000149	0.000201	CbGpPWpGaD
Imatinib—KIT—Disease—ERBB2—meningioma	0.000146	0.000197	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—TP53—meningioma	0.000145	0.000196	CbGpPWpGaD
Imatinib—CA14—Metabolism—AKT1—meningioma	0.000145	0.000195	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—PDGFB—meningioma	0.000144	0.000194	CbGpPWpGaD
Imatinib—CA6—Metabolism—AKT1—meningioma	0.000141	0.00019	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—TSHB—meningioma	0.00014	0.000189	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—ERBB2—meningioma	0.000139	0.000188	CbGpPWpGaD
Imatinib—PDGFRA—Disease—ERBB2—meningioma	0.000138	0.000186	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—TSHB—meningioma	0.000137	0.000185	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.000137	0.000185	CbGpPWpGaD
Imatinib—CA9—Metabolism—PTEN—meningioma	0.000136	0.000184	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—ERBB2—meningioma	0.000134	0.000182	CbGpPWpGaD
Imatinib—KIT—Immune System—PTEN—meningioma	0.000134	0.000182	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—AKT1—meningioma	0.000133	0.00018	CbGpPWpGaD
Imatinib—CA7—Metabolism—AKT1—meningioma	0.000132	0.000178	CbGpPWpGaD
Imatinib—ABL1—Immune System—ERBB2—meningioma	0.000131	0.000177	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ALAD—meningioma	0.000131	0.000177	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—PDGFB—meningioma	0.00013	0.000175	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—TSHB—meningioma	0.000129	0.000174	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—TSHB—meningioma	0.000128	0.000173	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—AKT1—meningioma	0.000128	0.000173	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—PTEN—meningioma	0.000127	0.000172	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—AKT1—meningioma	0.000126	0.00017	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—AKT1—meningioma	0.000125	0.000169	CbGpPWpGaD
Imatinib—PDGFRB—Disease—ERBB2—meningioma	0.000124	0.000168	CbGpPWpGaD
Imatinib—KIT—Disease—PTEN—meningioma	0.000124	0.000168	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—AKT1—meningioma	0.000123	0.000166	CbGpPWpGaD
Imatinib—CA12—Metabolism—AKT1—meningioma	0.000122	0.000165	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HES1—meningioma	0.000122	0.000164	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—AKT1—meningioma	0.000121	0.000163	CbGpPWpGaD
Imatinib—LCK—Hemostasis—TP53—meningioma	0.00012	0.000162	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—PTEN—meningioma	0.000119	0.00016	CbGpPWpGaD
Imatinib—PDGFRA—Disease—PTEN—meningioma	0.000117	0.000159	CbGpPWpGaD
Imatinib—ALB—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000117	0.000158	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000115	0.000156	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—PTEN—meningioma	0.000115	0.000155	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—AKT1—meningioma	0.000113	0.000153	CbGpPWpGaD
Imatinib—ABL1—Immune System—PTEN—meningioma	0.000112	0.000151	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—AKT1—meningioma	0.000111	0.000149	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—TSHB—meningioma	0.000109	0.000147	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—AKT1—meningioma	0.000109	0.000147	CbGpPWpGaD
Imatinib—LCK—Immune System—ERBB2—meningioma	0.000108	0.000146	CbGpPWpGaD
Imatinib—PDGFRB—Disease—PTEN—meningioma	0.000106	0.000143	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—PDGFB—meningioma	0.000104	0.000141	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—ERBB2—meningioma	0.000102	0.000138	CbGpPWpGaD
Imatinib—LCK—Hemostasis—AKT1—meningioma	0.000101	0.000137	CbGpPWpGaD
Imatinib—LCK—Disease—ERBB2—meningioma	9.96e-05	0.000135	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—ERBB2—meningioma	9.65e-05	0.00013	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—PTEN—meningioma	9.55e-05	0.000129	CbGpPWpGaD
Imatinib—CA2—Metabolism—AKT1—meningioma	9.32e-05	0.000126	CbGpPWpGaD
Imatinib—LCK—Immune System—PTEN—meningioma	9.2e-05	0.000124	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—AKT1—meningioma	9.1e-05	0.000123	CbGpPWpGaD
Imatinib—CA1—Metabolism—AKT1—meningioma	8.94e-05	0.000121	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—AKT1—meningioma	8.74e-05	0.000118	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—ERBB2—meningioma	8.69e-05	0.000117	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—PTEN—meningioma	8.69e-05	0.000117	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—meningioma	8.57e-05	0.000116	CbGpPWpGaD
Imatinib—LCK—Disease—PTEN—meningioma	8.49e-05	0.000115	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—TSHB—meningioma	8.42e-05	0.000114	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—PTEN—meningioma	8.23e-05	0.000111	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TP53—meningioma	8.09e-05	0.000109	CbGpPWpGaD
Imatinib—CA9—Metabolism—AKT1—meningioma	7.86e-05	0.000106	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—meningioma	7.81e-05	0.000106	CbGpPWpGaD
Imatinib—KIT—Immune System—AKT1—meningioma	7.75e-05	0.000105	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—PTEN—meningioma	7.41e-05	0.0001	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—AKT1—meningioma	7.33e-05	9.91e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—TP53—meningioma	7.16e-05	9.67e-05	CbGpPWpGaD
Imatinib—KIT—Disease—AKT1—meningioma	7.15e-05	9.66e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—ERBB2—meningioma	6.97e-05	9.42e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—PTEN—meningioma	6.89e-05	9.31e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—AKT1—meningioma	6.83e-05	9.24e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—PTEN—meningioma	6.83e-05	9.23e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PTEN—meningioma	6.82e-05	9.21e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—AKT1—meningioma	6.77e-05	9.15e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—meningioma	6.68e-05	9.02e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PTEN—meningioma	6.62e-05	8.94e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—AKT1—meningioma	6.61e-05	8.93e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—AKT1—meningioma	6.44e-05	8.7e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PTEN—meningioma	6.36e-05	8.59e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—AKT1—meningioma	6.1e-05	8.24e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—AKT1—meningioma	6.04e-05	8.17e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—PTEN—meningioma	5.95e-05	8.04e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TP53—meningioma	5.93e-05	8.01e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TP53—meningioma	5.61e-05	7.59e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—AKT1—meningioma	5.3e-05	7.16e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TP53—meningioma	5.06e-05	6.83e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—AKT1—meningioma	5.01e-05	6.77e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PTEN—meningioma	4.94e-05	6.67e-05	CbGpPWpGaD
Imatinib—LCK—Disease—AKT1—meningioma	4.89e-05	6.61e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—AKT1—meningioma	4.74e-05	6.41e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—AKT1—meningioma	4.27e-05	5.77e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—PTEN—meningioma	4.25e-05	5.74e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TP53—meningioma	4.06e-05	5.48e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—AKT1—meningioma	3.97e-05	5.37e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—AKT1—meningioma	3.94e-05	5.32e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—AKT1—meningioma	3.93e-05	5.31e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PTEN—meningioma	3.82e-05	5.16e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—AKT1—meningioma	3.81e-05	5.15e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PTEN—meningioma	3.72e-05	5.03e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—AKT1—meningioma	3.66e-05	4.95e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PTEN—meningioma	3.51e-05	4.74e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PTEN—meningioma	3.48e-05	4.7e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—AKT1—meningioma	3.43e-05	4.63e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PTEN—meningioma	2.97e-05	4.02e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—AKT1—meningioma	2.84e-05	3.84e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—AKT1—meningioma	2.45e-05	3.31e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PTEN—meningioma	2.29e-05	3.1e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—AKT1—meningioma	2.2e-05	2.97e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—AKT1—meningioma	2.15e-05	2.9e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—AKT1—meningioma	2.02e-05	2.73e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—AKT1—meningioma	2.01e-05	2.71e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—AKT1—meningioma	1.71e-05	2.32e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—AKT1—meningioma	1.32e-05	1.79e-05	CbGpPWpGaD
